Biotinidase deficiency: a treatable leukoencephalopathy
- PMID: 15328559
- DOI: 10.1055/s-2004-821080
Biotinidase deficiency: a treatable leukoencephalopathy
Abstract
The clinical history and the neuroradiological findings have been reviewed for 5 patients with biotinidase deficiency. Patients were diagnosed in the UK, where neonatal screening for this disorder is not done. The age at presentation ranged from 4 weeks to 5 months and the median interval between presentation and diagnosis was 5.5 months. The main abnormalities on cerebral imaging were leukoencephalopathy and widening of the ventricles and extra-cerebral CSF spaces. White matter abnormalities included delayed myelination but, in some patients, the increased signal was too great to be explained just by failure of myelination. Subtle subcortical changes were the only abnormality in one patient. Follow-up studies after treatment with biotin showed improved myelination; in one case, this was accompanied by normalisation of the CSF spaces but another patient showed progressive atrophy and cystic degeneration. Most of these patients have neurological sequelae. Biotinidase deficiency should be excluded in all patients with unexplained neurological problems. Neonatal screening provides the best chance of a good outcome.
Similar articles
-
Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.Brain. 2009 Jul;132(Pt 7):1764-82. doi: 10.1093/brain/awp112. Epub 2009 May 11. Brain. 2009. PMID: 19433437
-
Reversal of brain atrophy with biotin treatment in biotinidase deficiency.Neuropediatrics. 1993 Aug;24(4):214-7. doi: 10.1055/s-2008-1071543. Neuropediatrics. 1993. PMID: 8232780
-
A case of partial biotinidase deficiency associated with autism.Child Neuropsychol. 2003 Sep;9(3):184-8. doi: 10.1076/chin.9.3.184.16457. Child Neuropsychol. 2003. PMID: 13680408
-
Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature.Pediatr Neurol. 2011 Oct;45(4):261-4. doi: 10.1016/j.pediatrneurol.2011.06.010. Pediatr Neurol. 2011. PMID: 21907891 Review.
-
The neurology of biotinidase deficiency.Mol Genet Metab. 2011 Sep-Oct;104(1-2):27-34. doi: 10.1016/j.ymgme.2011.06.001. Epub 2011 Jun 12. Mol Genet Metab. 2011. PMID: 21696988 Review.
Cited by
-
Biotinidase deficiency: a reversible neurometabolic disorder (an Iranian pediatric case series).Iran J Child Neurol. 2013 Fall;7(4):47-52. Iran J Child Neurol. 2013. PMID: 24665318 Free PMC article.
-
Vitamin-responsive epileptic encephalopathies in children.Epilepsy Res Treat. 2013;2013:510529. doi: 10.1155/2013/510529. Epub 2013 Jul 25. Epilepsy Res Treat. 2013. PMID: 23984056 Free PMC article.
-
Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.Pediatr Radiol. 2008 Aug;38(8):848-56. doi: 10.1007/s00247-008-0904-z. Epub 2008 Jun 11. Pediatr Radiol. 2008. PMID: 18545994
-
Inborn Errors of Metabolism in Pediatric Epilepsy.J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):398-405. doi: 10.5863/1551-6776-24.5.398. J Pediatr Pharmacol Ther. 2019. PMID: 31598103 Free PMC article. Review.
-
Neuroimaging Features of Biotinidase Deficiency.AJNR Am J Neuroradiol. 2023 Mar;44(3):328-333. doi: 10.3174/ajnr.A7781. Epub 2023 Feb 9. AJNR Am J Neuroradiol. 2023. PMID: 36759144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical